Medicare Choices

Korn, Donald Jay
November 2007
Financial Planning;Nov2007, Vol. 37 Issue 11, p125
The article talks about evaluating Medicare private fee-for-service plans which have been growing in the U.S. It explains Medicare private fee-for-service plan. It cites that these plans do not have any network of healthcare providers. As a result of aggressive marketing, many Medicare beneficiaries started signing up for the plans.


Related Articles

  • Medicare: HCFA Faces Challenges to Control Improper Payments: T-HEHS-00-74. Aronovitz, Leslie G. // GAO Reports;3/9/2000, p1 

    Both the traditional Medicare program and Medicare+Choice contain major information gaps that impede the ability of the Health Care Financing Administration (HCFA) to minimize program losses attributable to improper payments to claims administration contractors. HCFA does not have a clear...

  • Improving the Care of ESRD Patients: A Success Story. McClellan, William M.; Frankenfield, Diane L.; Frederick, Pamela R.; Helgerson, Steven D.; Wish, Jay B.; Sugarman, Jonathan R. // Health Care Financing Review;Summer2003, Vol. 24 Issue 4, p89 

    Medicare's health care quality improvement program (HCQIP) is a national effort to improve beneficiaries' quality of care. The end stage renal disease (ESRD) HCQIP was implemented in 1994 in response to criticism about the poor quality of care received by ESRD patients. Quality improvement...

  • Medicare Calibration of the Clinically Detailed Risk Information System for Cost. Kapur, Kanika; Chien-Wen Tseng; Rastegar, Afshin; Carter, Grace M.; Keeler, Emmett // Health Care Financing Review;Fall2003, Vol. 25 Issue 1, p37 

    The clinically detailed risk information system for cost (CD-RISC) contains definitions for several hundred severity-adjusted conditions that can be used to predict future health care costs. We develop a prospective Medicare CD-RISC model using a 5-percent sample of Medicare beneficiaries and...

  • Medicare Part D and Low-Income Medicare Beneficiaries. Burns, Bonnie // Generations;Spring2005, Vol. 29 Issue 1, p91 

    The article explains that many Medicare beneficiaries, but especially dually eligible beneficiaries, will need local, individualized, face-to-face assistance when they are enrolling in Medicare Part D and selecting a prescription drug plan. They will need simple, clear instructions and...

  • Should you switch Medicare plans?  // Consumer Reports;Sep2004, Vol. 69 Issue 9, p51 

    Examines whether or not U.S. citizens enrolled in traditional Medicare should stay in the program, or switch to the alternative, called "Medicare Advantage." Description of pros and cons of each system with consideration for cost, benefits, and risks; Tips on choosing a plan based on lifestyle...

  • Medicare's Private Plans: A Report Card On Medicare Advantage. Gold, Marsha // Health Affairs;Jan/Feb2009, Vol. 28 Issue 1, pw41 

    With higher payments and expanded private-plan authority, Medicare Advantage (MA) has caused the market to grow. One in three Medicare beneficiaries with Part D now gets this coverage through MA. Analysis of the sources of and reasons for enrollment growth suggest a troubling report card....

  • SPECIAL REPORT: Defining A Future For Fee-For-Service Medicare. Foote, Susan Bartlett; Halaas, Gwen Wagstrom // Health Affairs;May/Jun2006, Vol. 25 Issue 3, p864 

    The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) provides economic incentives that favor health plans over traditional fee-for-service (FFS) Medicare. This reflects an ideological preference for private plans rather than government- administered pricing and recognition...

  • Laying the cornerstone for Medicare Part D. Wyeth, Jo; Kozak, Deborah // Drug Topics;8/22/2005, Vol. 149 Issue 16, p37 

    This article provides information on the Medicare Prescription Drug Benefit which is part of the Medicare Drug Improvement & Modernization Act of 2003 and the most comprehensive enhancement of the Medicare Program since it was created in 1965. The drug benefit offers affordable prescription drug...

  • Capping drug benefits does not reduce total medical costs.  // PharmacoEconomics & Outcomes News;6/17/2006, Issue 505, p4 

    The article discusses research being done on the total medical costs of patients whose drug benefits were capped and those whose benefits were not capped. It references a study by J. Hsu and colleagues in the June 2006 issue of the "New England Journal of Medicine." The researchers used a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics